However, inconsistent with the findings of this study, the expression of ATP2A1 in breast cancer tissues appears to be lower than in normal tissues, which may be due to the tumour heterogeneity (Christodoulou et al., 2021). This evidence concerns the gene ATP2A1 and breast carcinoma.